▶ 調査レポート

世界のナノ抗体市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Nano Antibodies Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のナノ抗体市場 2021:企業別、地域別、種類・用途別 / Global Nano Antibodies Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-2104Z09751資料のイメージです。• レポートコード:GIR-2104Z09751
• 出版社/出版日:GlobalInfoResearch / 2021年3月15日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療・医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ナノ抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ナノ抗体の種類別市場規模(一価ナノボディ、多価・多重特異性ナノボディ、融合ナノボディ)、用途別市場規模(生体外疾患検出、生体外非侵襲的診断、腫瘍標的療法、神経系疾患、循環器疾患、感染症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・ナノ抗体の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Ablynx、PREGENE、Alphamab、PersonGen
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:一価ナノボディ、多価・多重特異性ナノボディ、融合ナノボディ
・用途別分析2016年-2026年:生体外疾患検出、生体外非侵襲的診断、腫瘍標的療法、神経系疾患、循環器疾患、感染症、その他
・ナノ抗体の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ナノ抗体のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ナノ抗体のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ナノ抗体の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ナノ抗体の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nano Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nano Antibodies size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Nano Antibodies market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Nano Antibodies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Monovalent Nanobody
Multivalent and multispecific Nanobodies
Fusion Nanobody

Market segment by Application, can be divided into
Disease detection in vitro
Non-invasive diagnosis in vivo
Tumor targeted therapy
Nervous system disease
Circulatory disease
Infectious disease
Other

Market segment by players, this report covers
Ablynx
PREGENE
Alphamab
PersonGen

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Nano Antibodies
1.2 Classification of Nano Antibodies by Type
1.2.1 Overview: Global Nano Antibodies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Nano Antibodies Revenue Market Share by Type in 2020
1.2.3 Monovalent Nanobody
1.2.4 Multivalent and multispecific Nanobodies
1.2.5 Fusion Nanobody
1.3 Global Nano Antibodies Market by Application
1.3.1 Overview: Global Nano Antibodies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Disease detection in vitro
1.3.3 Non-invasive diagnosis in vivo
1.3.4 Tumor targeted therapy
1.3.5 Nervous system disease
1.3.6 Circulatory disease
1.3.7 Infectious disease
1.3.8 Other
1.4 Global Nano Antibodies Market Size & Forecast
1.5 Global Nano Antibodies Market Size and Forecast by Region
1.5.1 Global Nano Antibodies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Nano Antibodies Market Size by Region, (2016-2021)
1.5.3 North America Nano Antibodies Market Size and Prospect (2016-2026)
1.5.4 Europe Nano Antibodies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Nano Antibodies Market Size and Prospect (2016-2026)
1.5.6 South America Nano Antibodies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Nano Antibodies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Nano Antibodies Market Drivers
1.6.2 Nano Antibodies Market Restraints
1.6.3 Nano Antibodies Trends Analysis
2 Company Profiles
2.1 Ablynx
2.1.1 Ablynx Details
2.1.2 Ablynx Major Business
2.1.3 Ablynx Nano Antibodies Product and Solutions
2.1.4 Ablynx Nano Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Ablynx Recent Developments and Future Plans
2.2 PREGENE
2.2.1 PREGENE Details
2.2.2 PREGENE Major Business
2.2.3 PREGENE Nano Antibodies Product and Solutions
2.2.4 PREGENE Nano Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 PREGENE Recent Developments and Future Plans
2.3 Alphamab
2.3.1 Alphamab Details
2.3.2 Alphamab Major Business
2.3.3 Alphamab Nano Antibodies Product and Solutions
2.3.4 Alphamab Nano Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Alphamab Recent Developments and Future Plans
2.4 PersonGen
2.4.1 PersonGen Details
2.4.2 PersonGen Major Business
2.4.3 PersonGen Nano Antibodies Product and Solutions
2.4.4 PersonGen Nano Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 PersonGen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nano Antibodies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Nano Antibodies Players Market Share
3.2.2 Top 10 Nano Antibodies Players Market Share
3.2.3 Market Competition Trend
3.3 Nano Antibodies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Nano Antibodies Revenue and Market Share by Type (2016-2021)
4.2 Global Nano Antibodies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Nano Antibodies Revenue Market Share by Application (2016-2021)
5.2 Nano Antibodies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Nano Antibodies Revenue by Type (2016-2026)
6.2 North America Nano Antibodies Revenue by Application (2016-2026)
6.3 North America Nano Antibodies Market Size by Country
6.3.1 North America Nano Antibodies Revenue by Country (2016-2026)
6.3.2 United States Nano Antibodies Market Size and Forecast (2016-2026)
6.3.3 Canada Nano Antibodies Market Size and Forecast (2016-2026)
6.3.4 Mexico Nano Antibodies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Nano Antibodies Revenue by Type (2016-2026)
7.2 Europe Nano Antibodies Revenue by Application (2016-2026)
7.3 Europe Nano Antibodies Market Size by Country
7.3.1 Europe Nano Antibodies Revenue by Country (2016-2026)
7.3.2 Germany Nano Antibodies Market Size and Forecast (2016-2026)
7.3.3 France Nano Antibodies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Nano Antibodies Market Size and Forecast (2016-2026)
7.3.5 Russia Nano Antibodies Market Size and Forecast (2016-2026)
7.3.6 Italy Nano Antibodies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Nano Antibodies Revenue by Type (2016-2026)
8.2 Asia-Pacific Nano Antibodies Revenue by Application (2016-2026)
8.3 Asia-Pacific Nano Antibodies Market Size by Region
8.3.1 Asia-Pacific Nano Antibodies Revenue by Region (2016-2026)
8.3.2 China Nano Antibodies Market Size and Forecast (2016-2026)
8.3.3 Japan Nano Antibodies Market Size and Forecast (2016-2026)
8.3.4 South Korea Nano Antibodies Market Size and Forecast (2016-2026)
8.3.5 India Nano Antibodies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Nano Antibodies Market Size and Forecast (2016-2026)
8.3.7 Australia Nano Antibodies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Nano Antibodies Revenue by Type (2016-2026)
9.2 South America Nano Antibodies Revenue by Application (2016-2026)
9.3 South America Nano Antibodies Market Size by Country
9.3.1 South America Nano Antibodies Revenue by Country (2016-2026)
9.3.2 Brazil Nano Antibodies Market Size and Forecast (2016-2026)
9.3.3 Argentina Nano Antibodies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Nano Antibodies Revenue by Type (2016-2026)
10.2 Middle East & Africa Nano Antibodies Revenue by Application (2016-2026)
10.3 Middle East & Africa Nano Antibodies Market Size by Country
10.3.1 Middle East & Africa Nano Antibodies Revenue by Country (2016-2026)
10.3.2 Turkey Nano Antibodies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Nano Antibodies Market Size and Forecast (2016-2026)
10.3.4 UAE Nano Antibodies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Nano Antibodies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Nano Antibodies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Nano Antibodies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Nano Antibodies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Nano Antibodies Revenue Market Share by Region (2021-2026)
Table 6. Ablynx Corporate Information, Head Office, and Major Competitors
Table 7. Ablynx Major Business
Table 8. Ablynx Nano Antibodies Product and Solutions
Table 9. Ablynx Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. PREGENE Corporate Information, Head Office, and Major Competitors
Table 11. PREGENE Major Business
Table 12. PREGENE Nano Antibodies Product and Solutions
Table 13. PREGENE Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Alphamab Corporate Information, Head Office, and Major Competitors
Table 15. Alphamab Major Business
Table 16. Alphamab Nano Antibodies Product and Solutions
Table 17. Alphamab Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. PersonGen Corporate Information, Head Office, and Major Competitors
Table 19. PersonGen Major Business
Table 20. PersonGen Nano Antibodies Product and Solutions
Table 21. PersonGen Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Nano Antibodies Revenue (USD Million) by Players (2019-2021)
Table 23. Global Nano Antibodies Revenue Share by Players (2019-2021)
Table 24. Breakdown of Nano Antibodies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Nano Antibodies Players Head Office, Products and Services Provided
Table 26. Nano Antibodies Mergers & Acquisitions in the Past Five Years
Table 27. Nano Antibodies New Entrants and Expansion Plans
Table 28. Global Nano Antibodies Revenue (USD Million) by Type (2016-2021)
Table 29. Global Nano Antibodies Revenue Share by Type (2016-2021)
Table 30. Global Nano Antibodies Revenue Forecast by Type (2021-2026)
Table 31. Global Nano Antibodies Revenue by Application (2016-2021)
Table 32. Global Nano Antibodies Revenue Forecast by Application (2021-2026)
Table 33. North America Nano Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Nano Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Nano Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Nano Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Nano Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Nano Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Nano Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Nano Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Nano Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Nano Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Nano Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Nano Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Nano Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Nano Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Nano Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Nano Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Nano Antibodies Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Nano Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Nano Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Nano Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Nano Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Nano Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Nano Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Nano Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Nano Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Nano Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Nano Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Nano Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Nano Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Nano Antibodies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Nano Antibodies Picture
Figure 2. Global Nano Antibodies Revenue Market Share by Type in 2020
Figure 3. Monovalent Nanobody
Figure 4. Multivalent and multispecific Nanobodies
Figure 5. Fusion Nanobody
Figure 6. Nano Antibodies Revenue Market Share by Application in 2020
Figure 7. Disease detection in vitro Picture
Figure 8. Non-invasive diagnosis in vivo Picture
Figure 9. Tumor targeted therapy Picture
Figure 10. Nervous system disease Picture
Figure 11. Circulatory disease Picture
Figure 12. Infectious disease Picture
Figure 13. Other Picture
Figure 14. Global Nano Antibodies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Nano Antibodies Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Nano Antibodies Revenue Market Share by Region (2016-2026)
Figure 17. Global Nano Antibodies Revenue Market Share by Region in 2020
Figure 18. North America Nano Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Nano Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Nano Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Nano Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Nano Antibodies Market Drivers
Figure 23. Nano Antibodies Market Restraints
Figure 24. Nano Antibodies Market Trends
Figure 25. Ablynx Recent Developments and Future Plans
Figure 26. PREGENE Recent Developments and Future Plans
Figure 27. Alphamab Recent Developments and Future Plans
Figure 28. PersonGen Recent Developments and Future Plans
Figure 30. Global Nano Antibodies Revenue Share by Players in 2020
Figure 31. Nano Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Nano Antibodies Revenue Market Share in 2020
Figure 33. Global Top 10 Players Nano Antibodies Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Nano Antibodies Revenue Share by Type in 2020
Figure 36. Global Nano Antibodies Market Share Forecast by Type (2021-2026)
Figure 37. Global Nano Antibodies Revenue Share by Application in 2020
Figure 38. Global Nano Antibodies Market Share Forecast by Application (2021-2026)
Figure 39. North America Nano Antibodies Sales Market Share by Type (2016-2026)
Figure 40. North America Nano Antibodies Sales Market Share by Application (2016-2026)
Figure 41. North America Nano Antibodies Revenue Market Share by Country (2016-2026)
Figure 42. United States Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Nano Antibodies Sales Market Share by Type (2016-2026)
Figure 46. Europe Nano Antibodies Sales Market Share by Application (2016-2026)
Figure 47. Europe Nano Antibodies Revenue Market Share by Country (2016-2026)
Figure 48. Germany Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Nano Antibodies Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Nano Antibodies Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Nano Antibodies Revenue Market Share by Region (2016-2026)
Figure 56. China Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Nano Antibodies Sales Market Share by Type (2016-2026)
Figure 63. South America Nano Antibodies Sales Market Share by Application (2016-2026)
Figure 64. South America Nano Antibodies Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Nano Antibodies Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Nano Antibodies Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Nano Antibodies Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Nano Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source